Luyan Pharma Co Ltd (002788) - Total Liabilities
Based on the latest financial reports, Luyan Pharma Co Ltd (002788) has total liabilities worth CN¥9.95 Billion CNY (≈ $1.46 Billion USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore Luyan Pharma Co Ltd net asset momentum to track the company's year-over-year net asset growth rate.
Luyan Pharma Co Ltd - Total Liabilities Trend (2011–2025)
This chart illustrates how Luyan Pharma Co Ltd's total liabilities have evolved over time, based on quarterly financial data. See 002788 free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
Luyan Pharma Co Ltd Competitors by Total Liabilities
The table below lists competitors of Luyan Pharma Co Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Bar Harbor Bankshares Inc
NYSE MKT:BHB
|
USA | $4.14 Billion |
|
Haier Smart Home Co Ltd
F:690D
|
Germany | €165.78 Billion |
|
Australian Agricultural Company Ltd
AU:AAC
|
Australia | AU$930.75 Million |
|
Beijing Career International Co Ltd
SHE:300662
|
China | CN¥1.99 Billion |
|
Veken Elite
SHG:600152
|
China | CN¥1.30 Billion |
|
Universal Cement Corp
TW:1104
|
Taiwan | NT$5.62 Billion |
|
Jensen-Group NV
BR:JEN
|
Belgium | €194.66 Million |
|
First Mining Gold Corp
TO:FF
|
Canada | CA$97.62 Million |
Liability Composition Analysis (2011–2025)
This chart breaks down Luyan Pharma Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Luyan Pharma Co Ltd market capitalisation.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.11 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 2.95 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.75 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Luyan Pharma Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Luyan Pharma Co Ltd (2011–2025)
The table below shows the annual total liabilities of Luyan Pharma Co Ltd from 2011 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | CN¥10.07 Billion ≈ $1.47 Billion |
+6.62% |
| 2024-12-31 | CN¥9.45 Billion ≈ $1.38 Billion |
+7.15% |
| 2023-12-31 | CN¥8.82 Billion ≈ $1.29 Billion |
-1.96% |
| 2022-12-31 | CN¥8.99 Billion ≈ $1.32 Billion |
+21.00% |
| 2021-12-31 | CN¥7.43 Billion ≈ $1.09 Billion |
+23.29% |
| 2020-12-31 | CN¥6.03 Billion ≈ $882.18 Million |
+6.70% |
| 2019-12-31 | CN¥5.65 Billion ≈ $826.77 Million |
+27.92% |
| 2018-12-31 | CN¥4.42 Billion ≈ $646.34 Million |
+23.86% |
| 2017-12-31 | CN¥3.57 Billion ≈ $521.83 Million |
+67.16% |
| 2016-12-31 | CN¥2.13 Billion ≈ $312.17 Million |
-20.49% |
| 2015-12-31 | CN¥2.68 Billion ≈ $392.61 Million |
+0.69% |
| 2014-12-31 | CN¥2.66 Billion ≈ $389.93 Million |
+17.50% |
| 2013-12-31 | CN¥2.27 Billion ≈ $331.85 Million |
+27.67% |
| 2012-12-31 | CN¥1.78 Billion ≈ $259.93 Million |
+82.53% |
| 2011-12-31 | CN¥973.17 Million ≈ $142.40 Million |
-- |
About Luyan Pharma Co Ltd
Luyan Pharma Co.,Ltd., together with its subsidiaries, engages in the research, development, production, and sale of pharmaceutical products in China. The company distributes medicines, Chinese herbal medicines, medical devices, and others; and provides medical care, elderly care, and wellness services. It also operates pharmaceutical retail chains. The company was formerly known as Luyan (Fujian… Read more